MEDIAMO
Company: Mediamo S.r.l.
Sector: Mediation (Alternative Dispute Resolution) and training
Deal: Start-up
Equity stake: qualified minority
Status: in portfolio
Website: www.mediamo.it
Mediamo is a company whose aim is to promote mediation and conciliation in civil and commercial disputes, managing mediation procedures and organizing training courses for mediators. Mediamo is qualified by the Italian Ministry of Justice both to train mediators in civil and commercial disputes and to act as official ADR player. The Company is a benchmark and a center of excellence for mediation in Italy.
SAFEATWORK
Company: SAW S.r.l.
Sector: NFC solutions in the safety sector
Deal: Start-up
Equity stake: majority
Status: in portfolio
Website: www.safeatwork.it
SAW allows an active management of company’s procedures and a continuous, rigorous and active control of operations compliance, by simply touching with a mobile phone the tags applied in-field to systems, tools, machines, equipment, etc.
Exploiting the so called “proof of presence” solution, based on NFC technology (Near Field Communication), the SAW solution consists of an integrated system to support both management and control of activities “of the field“.
THERMOKEY
Company: Thermokey S.p.A.
Sector: Design and production of heat exchangers
Deal: Expansion – Soft Turnaround
Equity stake: syndacated control stake
Status: in portfolio
Website: www.thermokey.it
Thermokey, founded in 1991, has been producing various kinds of heat exchangers for 25 years now. It is internationally known as the ideal partner for manufacturers of tailor made cooling machines for air conditioning, refrigeration and process cooling. Thermokey heat exchangers range, becoming richer year after year, at the moment includes finned pack heat exchangers, air condensers, liquid coolers, unit coolers, shell and tube evaporators and condensers and brazed plate heat exchangers. Thermokey has 170 employees and workers. All Thermokey products are developed and manufactured in-house The commercial organisation includes, on top of the head quarter in Rivarotta di Rivignano Teor (UD), three different companies based in France, Germany and Poland, as well as a widely spread network of distributors in Europe, in the Middle East, in the Far East and in Latin America.
Companies: Sidam S.r.l. and Synopo S.p.A. – BTC Medical Europe S.r.l.
Sector: Design, production and distribution of disposables for medical devices
Deal: Expansion
Equity stake: 50%
Status: in portfolio
Website: www.synopo.it – www.sidamgroup.com – www.btcmedicaleurope.it
Founded in 1991, Sidam operates in the Mirandola biomedical district, the second one in the world. Sidam has been active for more than 20 years in the design and production of disposables for medical devices such as for magnetic resonance imaging contrast agents. A control stake (90%) of Sidam was achieved through an investment in Synopo, a distributor of medical devices, produced by Natus, in the neurological segment, used in hospitals, clinics and laboratories.
In December 2016 Sidam bought a control stake in BTC Medical Europe, a company based in Valeggio and Nonantola, with similar technologies and products but with a complementary market, being active in the postoperative blood recovery and oncology sectors.
MANTIS
Company: Mantis S.r.l.
Sector: beauty and aesthetic medicine sectors
Deal: Start-up (in an advanced phase)
Equity stake: minority
Status: in portfolio
Website: www.mantisitalia.it
Mantis, company focused on the cosmetic medicine sector, was founded in 2013. The Company has been producing – leveraging on the disruptive innovations coming from its in house centre for bio-medical electronics – a numerous of patented apparatus that are profitably sold around the word.
In 2015 the Company started selling its innovative products, reaching a turnover of about 3 million Euros.
Company: Stem Sel S.r.l.
Sector: Stem cell therapy applications in regenerative medicine
Deal: Start-up
Equity stake: minority
Status: in portfolio
Website: www.stemsel.it
Stem Sel Srl is a company founded in 2013 and spun off from the University of Bologna. The Stem Sel business is based on the development, engineering, production and commercialization of an instrumentation, consumables included, called Celector, an innovative and patented technology for the tag-less separation and selection of human stem cells from adult “discarded” tissues (e.g. placenta, umbilical cord, lipoaspirate, dental pulp) for stem cell therapy applications in regenerative medicine, with high growth market prospects. The competitive advantage of Celector lies in its ability to sort and select stem cells without any manipulation and no immunolabeling. In particular the absence of labeling avoids the possible cellular alteration and preserves their native regenerative power, selecting the stem cells for which there are currently no efficient technologies available on the market.